glp-1 drugs for parkinson's disease Are we measuring the wrong primary outcome for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep GLP-1 Receptor Agonists: A New

Find Your Match Our team helps you understand every option so you can decide with confidence

Bullock et al., 2014)

After 6 weeks, patients were then randomized to IGlarLixi or glargine

Cofounder and CEO Marc Washington, who started pitching his wares as Natures Ozempic a few months ago (a claim some legal experts have urged food brands to avoid), is now being inundated with inquiries as retailers such as Sprouts [which has just launched his brand nationwide] seek to capitalize on consumer interest in Supergut, which has historically been positioned as a gut health product

Accordingly, integration of structured nutritional surveillance with pharmacological therapy may represent an important component of long-term GLP-1RA management